Portal de Periódicos da CAPES

A Nationwide Survey of Practicing Urologists: Current Management of Benign Prostatic Hyperplasia and Clinically Localized Prostate Cancer

1997; Lippincott Williams & Wilkins; Volume: 158; Issue: 2 Linguagem: Inglês

10.1016/s0022-5347(01)64510-5

1527-3792

Michael J. Barry, Floyd J. Fowler, Bin Lin, Joseph E. Oesterling,

Genital Health and Disease

No AccessJournal of UrologyClinical Urology: Original Articles1 Aug 1997A Nationwide Survey of Practicing Urologists: Current Management of Benign Prostatic Hyperplasia and Clinically Localized Prostate Cancer Michael J. Barry, Floyd J. Fowler, Lin Bin, and Joseph E. Oesterling Michael J. BarryMichael J. Barry , Floyd J. FowlerFloyd J. Fowler , Lin BinLin Bin , and Joseph E. OesterlingJoseph E. Oesterling View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)64510-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Our aim was to define the spectrum of urological care for benign prostatic hyperplasia (BPH) and clinically localized prostate cancer. Materials and Methods: In 1995 a random sample of 394 American urologists was surveyed with a response rate of 67%. Results: Respondents reported seeing a median of 240 BPH patients during the preceding 12 months, and they had prescribed alpha-blockers for 70 and finasteride for 15. They had performed a median of 25 transurethral prostatectomies but few other operations for BPH. Almost all urologists routinely used digital rectal examinations and prostate specific antigen tests for BPH diagnosis. The next most common studies were American Urological Association symptom scores and uroflowmetry. Pressure-flow studies were rarely done. Respondents reported seeing a median of 35 new patients with prostate cancer during the last year, and performing a median of 90 prostate biopsies and 13 radical prostatectomies. Respondents had referred a median of 10 patients for external beam radiotherapy but few patients received brachytherapy or cryotherapy. Urologist staging practices varied considerably. Conclusions: These data provide a picture of current practice regarding the management of BPH and prostate cancer. References 1 : Epidemiology and natural history of BPH. In: The 3rd International Consultation on BPH: Proceedings. Edited by . Paris: Scientific Communication International1996: 21. Google Scholar 2 : Cancer statistics, 1996.. CA1996; 46: 5. Google Scholar 3 : Benign prostatic hyperplasia. Medical and minimally invasive treatment options.. New Engl. J. Med.1995; 332: 99. Google Scholar 4 : Benign Prostatic Hyperplasia: Diagnosis and Treatment. Rockville, Maryland: United States Department of Health and Human ServicesFebruary 1994. Google Scholar 5 : Detailed diagnoses and procedures, national hospital discharge survey: 1987. Vital Health Stat., series1989; 13: 295. Google Scholar 6 : Detailed diagnoses and procedures, national hospital discharge survey: 1993. Vital Health Stat., series1995; 13: 128. Google Scholar 7 : The role of increasing detection in the rising incidence of prostate cancer.. J.A.M.A.1995; 273: 548. Google Scholar 8 : Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing.. J.A.M.A.1995; 274: 1445. Google Scholar 9 : The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.. J.A.M.A.1993; 269: 57. Google Scholar 10 : Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.. Urology1995; 46: 2. Google Scholar 11 : Fundamentals of Biostatistics. Boston: PWS-Kent Publishing Co.1990: 293. Google Scholar 12 : The American Urological Association symptom index for benign prostatic hyperplasia.. J. Urol.1992; 148: 1549. Abstract, Google Scholar 13 : In support of pressure-flow studies for evaluating men with lower urinary tract symptoms.. Urology1994; 44: 153. Google Scholar 14 : Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.. J. Urol.1995; 154: 205. Abstract, Google Scholar 15 : Practice trends in the diagnosis and management of prostate cancer in the United States.. J. Urol.1995; 154: 207. Abstract, Google Scholar 16 : Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.. J. Urol.1991; 145: 313. Abstract, Google Scholar 17 : Routine estimation of prostate specific antigen prior to clinic attendance in patients with symptoms of bladder outlet obstruction.. Brit. J. Urol.1993; 72: 187. Google Scholar 18 : Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection.. Urology1995; 45: 270. Google Scholar 19 : Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.. J. Urol.1994; 151: 1315. Abstract, Google Scholar 20 : Open pelvic lymph node dissection for prostate cancer: a reassessment.. Urology1995; 46: 352. Google Scholar 21 : Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.. New Engl. J. Med1990; 323: 621. Google Scholar 22 : Are pelvic computed tomography, bone scan, and pelvic lymphadenectomy necessary in the staging of prostate cancer? Brit.. J. Urol.1995; 75: 778. Google Scholar Medical Practices Evaluation Center, Massachusetts General Hospital and Harvard Medical School, and Center for Survey Research, University of Massachusetts-Boston, Boston, Massachusetts, and Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan.© 1997 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited bySung J, Curtis L, Schulman K and Albala D (2018) Geographic Variations in the Use of Medical and Surgical Therapies for Benign Prostatic HyperplasiaJournal of Urology, VOL. 175, NO. 3, (1023-1027), Online publication date: 1-Mar-2006.LOTAN Y, CADEDDU J, ROEHRBORN C and STAGE K (2018) THE VALUE OF YOUR TIME: EVALUATION OF EFFECTS OF CHANGES IN MEDICARE REIMBURSEMENT RATES ON THE PRACTICE OF UROLOGYJournal of Urology, VOL. 172, NO. 5, (1958-1962), Online publication date: 1-Nov-2004.POULAKIS V, WITZSCH U, DE VRIES R, EMMERLICH V, MEVES M, ALTMANNSBERGER H and BECHT E (2018) PREOPERATIVE NEURAL NETWORK USING COMBINED MAGNETIC RESONANCE IMAGING VARIABLES, PROSTATE SPECIFIC ANTIGEN AND GLEASON SCORE TO PREDICT PROSTATE CANCER STAGEJournal of Urology, VOL. 172, NO. 4 Part 1, (1306-1310), Online publication date: 1-Oct-2004.WILT T, MacDONALD R and NELSON D (2018) TAMSULOSIN FOR TREATING LOWER URINARY TRACT SYMPTOMS COMPATIBLE WITH BENIGN PROSTATIC OBSTRUCTION: A SYSTEMATIC REVIEW OF EFFICACY AND ADVERSE EFFECTSJournal of Urology, VOL. 167, NO. 1, (177-183), Online publication date: 1-Jan-2002.ALBERTSEN P, HANLEY J, HARLAN L, GILLILAND F, HAMILTON A, LIFF J, STANFORD J and STEPHENSON R (2018) THE POSITIVE YIELD OF IMAGING STUDIES IN THE EVALUATION OF MEN WITH NEWLY DIAGNOSED PROSTATE CANCER: A POPULATION BASED ANALYSISJournal of Urology, VOL. 163, NO. 4, (1138-1143), Online publication date: 1-Apr-2000.LEPOR H, JONES K and WILLIFORD W (2018) THE MECHANISM OF ADVERSE EVENTS ASSOCIATED WITH TERAZOSIN: AN ANALYSIS OF THE VETERANS AFFAIRS COOPERATIVE STUDYJournal of Urology, VOL. 163, NO. 4, (1134-1137), Online publication date: 1-Apr-2000.RAMSEY E, ELHILALI M, GOLDENBERG S, NICKEL C, NORMAN R, PERREAULT J, PIERCY B and COUNCIL J (2018) PRACTICE PATTERNS OF CANADIAN UROLOGISTS IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCERJournal of Urology, VOL. 163, NO. 2, (499-502), Online publication date: 1-Feb-2000.SONKE G, HESKES T, VERBEEK A, DE LA ROSETTE J and KIEMENEY L (2018) PREDICTION OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS USING ARTIFICIAL NEURAL NETWORKSJournal of Urology, VOL. 163, NO. 1, (300-305), Online publication date: 1-Jan-2000.KINDRICK A, GROSSFELD G, STIER D, FLANDERS S, HENNING J and CARROLL P (2018) USE OF IMAGING TESTS FOR STAGING NEWLY DIAGNOSED PROSTATE CANCER: TRENDS FROM THE CAPSURE DATABASEJournal of Urology, VOL. 160, NO. 6 Part 1, (2102-2106), Online publication date: 1-Dec-1998.TEWARI A and NARAYAN P (2018) NOVEL STAGING TOOL FOR LOCALIZED PROSTATE CANCER: A PILOT STUDY USING GENETIC ADAPTIVE NEURAL NETWORKSJournal of Urology, VOL. 160, NO. 2, (430-436), Online publication date: 1-Aug-1998. Volume 158Issue 2August 1997Page: 488-492 Advertisement Copyright & Permissions© 1997 by American Urological Association, Inc.Metrics Author Information Michael J. Barry More articles by this author Floyd J. Fowler More articles by this author Lin Bin More articles by this author Joseph E. Oesterling More articles by this author Expand All Advertisement PDF downloadLoading ...